Mark D. Plinio serves as Executive at Evelo Biosciences, Inc., where they oversee executive responsibilities. Since joining the company, Mark D. Plinio has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 31, 2023 involved receiving (via award) 1,250 shares valued at $1.1K.
Mark D. Plinio currently holds 3,750 shares of Evelo Biosciences, Inc. (EVLO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark D. Plinio has been a net neutral trader of EVLO stock. They have purchased $0 and sold $0 worth of shares.
Mark D. Plinio's most recent insider trade was on Jan 31, 2023, when they sold 1,250 shares at $0.88 per share.
Get notified when new Form 4 filings are submitted
| $1.79 |
| Discretionary |
| Jan 31, 2022 | EVLO | $5.0K | Award | 1,250 | $4.00 | Discretionary |